These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30042192)

  • 41. Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease.
    Koptides M; Mean R; Demetriou K; Pierides A; Deltas CC
    Hum Mol Genet; 2000 Feb; 9(3):447-52. PubMed ID: 10655555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease.
    Obeidova L; Elisakova V; Stekrova J; Reiterova J; Merta M; Tesar V; Losan F; Kohoutova M
    BMC Med Genet; 2014 Apr; 15():41. PubMed ID: 24694054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations.
    Watnick T; He N; Wang K; Liang Y; Parfrey P; Hefferton D; St George-Hyslop P; Germino G; Pei Y
    Nat Genet; 2000 Jun; 25(2):143-4. PubMed ID: 10835625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High Resolution Melt analysis for mutation screening in PKD1 and PKD2.
    Bataille S; Berland Y; Fontes M; Burtey S
    BMC Nephrol; 2011 Oct; 12():57. PubMed ID: 22008521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
    Senum SR; Li YSM; Benson KA; Joli G; Olinger E; Lavu S; Madsen CD; Gregory AV; Neatu R; Kline TL; Audrézet MP; Outeda P; Nau CB; Meijer E; Ali H; Steinman TI; Mrug M; Phelan PJ; Watnick TJ; Peters DJM; Ong ACM; Conlon PJ; Perrone RD; Cornec-Le Gall E; Hogan MC; Torres VE; Sayer JA; ; Harris PC
    Am J Hum Genet; 2022 Jan; 109(1):136-156. PubMed ID: 34890546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.
    Leonhard WN; Zandbergen M; Veraar K; van den Berg S; van der Weerd L; Breuning M; de Heer E; Peters DJ
    J Am Soc Nephrol; 2015 Jun; 26(6):1322-33. PubMed ID: 25361818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 48. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
    Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel PKD1 and PKD2 mutations in Taiwanese patients with autosomal dominant polycystic kidney disease.
    Chang MY; Chen HM; Jenq CC; Lee SY; Chen YM; Tian YC; Chen YC; Hung CC; Fang JT; Yang CW; Wu-Chou YH
    J Hum Genet; 2013 Nov; 58(11):720-7. PubMed ID: 23985799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A missense mutation in PKD1 attenuates the severity of renal disease.
    Pei Y; Lan Z; Wang K; Garcia-Gonzalez M; He N; Dicks E; Parfrey P; Germino G; Watnick T
    Kidney Int; 2012 Feb; 81(4):412-7. PubMed ID: 22031115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD.
    Leuenroth SJ; Bencivenga N; Chahboune H; Hyder F; Crews CM
    Nephrol Dial Transplant; 2010 Jul; 25(7):2187-94. PubMed ID: 20139063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease.
    Tan YC; Blumenfeld JD; Anghel R; Donahue S; Belenkaya R; Balina M; Parker T; Levine D; Leonard DG; Rennert H
    Hum Mutat; 2009 Feb; 30(2):264-73. PubMed ID: 18837007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Heterozygosity loss and somatic mutations in type I and II dominant autosomal renal polycystic kidney disease: evidence of a recessive mechanism at a cell level in cystogenesis].
    Pérez-Oller L; Torra R; Badenas C; San Millán JL; Darnell A
    Nefrologia; 2000; 20(2):130-8. PubMed ID: 10853193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele.
    Reiterová J; Štekrová J; Merta M; Kotlas J; Elišáková V; Lněnička P; Korabečná M; Kohoutová M; Tesař V
    BMC Nephrol; 2013 Mar; 14():59. PubMed ID: 23496908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System.
    Kinoshita M; Higashihara E; Kawano H; Higashiyama R; Koga D; Fukui T; Gondo N; Oka T; Kawahara K; Rigo K; Hague T; Katsuragi K; Sudo K; Takeshi M; Horie S; Nutahara K
    PLoS One; 2016; 11(11):e0166288. PubMed ID: 27835667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease.
    Hwang YH; Conklin J; Chan W; Roslin NM; Liu J; He N; Wang K; Sundsbak JL; Heyer CM; Haider M; Paterson AD; Harris PC; Pei Y
    J Am Soc Nephrol; 2016 Jun; 27(6):1861-8. PubMed ID: 26453610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction.
    He WB; Xiao WJ; Tan YQ; Zhao XM; Li W; Zhang QJ; Zhong CG; Li XR; Hu L; Lu GX; Lin G; Du J
    BMC Med Genet; 2018 Oct; 19(1):186. PubMed ID: 30333007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bialleleic PKD1 mutations underlie early-onset autosomal dominant polycystic kidney disease in Saudi Arabian families.
    Al-Hamed MH; Alsahan N; Rice SJ; Edwards N; Nooreddeen E; Alotaibi M; Kurdi W; Alnemer M; Altaleb N; Ali W; Al-Numair N; Almejaish N; Sayer JA; Imtiaz F
    Pediatr Nephrol; 2019 Sep; 34(9):1615-1623. PubMed ID: 31079206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients.
    Ali H; Alahmad B; Senum SR; Warsame S; Bahbahani Y; Abu-Farha M; Abubaker J; Alqaddoumi M; Al-Mulla F; Harris PC
    Am J Nephrol; 2024; 55(3):380-388. PubMed ID: 38194940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autosomal dominant polycystic kidney disease (ADPKD) in Tunisia: From molecular genetics to the development of prognostic tools.
    Abdelwahed M; Hilbert P; Ahmed A; Dey M; Bouomrani S; Kamoun H; Ammar-Keskes L; Belguith N
    Gene; 2022 Apr; 817():146174. PubMed ID: 35031424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.